欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3137/001
药品名称Srivasso 18 microgram, inhalation powder, hard capsule
活性成分
    • tiotropium bromide 18.0 µg
剂型Inhalation powder, hard capsule
上市许可持有人Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein
参考成员国 - 产品名称Netherlands (NL)
Srivasso 18 microgram, inhalatiepoeder in harde capsules
互认成员国 - 产品名称
    • Germany (DE)
      Srivasso 18 Mikrogramm Hartkapseln mit Pulver zur Inhalation
    • Belgium (BE)
      Srivasso 18 microgrammes poudre pour inhalation en gélule
    • Luxembourg (LU)
    • Austria (AT)
      Srivasso 18 Mikrogramm Hartkapseln mit Pulver zur Inhalation
    • Portugal (PT)
    • Greece (GR)
      SRIVASSO® GENAHALER (ex TIOTROPIUM BROMIDE/TIOVENT® INPRESGO)
    • Sweden (SE)
    • Finland (FI)
    • Poland (PL)
      Srivasso
    • Hungary (HU)
      SRIVASSO 18 mikrogramm inhalációs por kemény kapszulában
    • Bulgaria (BG)
      Tiotropium bromide Inpresgo
    • Cyprus (CY)
      Tiotropium bromide lnpresgo 18 microgram, inhalation powder, hard capsule
    • Romania (RO)
      SRIVASSO 18 micrograme capsule cu pulbere de inhalat
    • Slovenia (SI)
    • Liechtenstein (LI)
许可日期2015/06/24
最近更新日期2024/09/04
药物ATC编码
    • R03BB04 tiotropium bromide
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase